Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06616857 · ClinicalTrials.gov registry record · NA
Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
A NA study of Cystic Fibrosis (CF), sponsored by Nemours Children's Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06616857: Recruiting NA study of Cystic Fibrosis (CF), sponsored by Nemours Children's Clinic.
NCT06616857 is a NA study of Cystic Fibrosis (CF) that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 30 participants, below the 139-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06616857, a NA study of Cystic Fibrosis (CF), is actively recruiting participants, sponsored by Nemours Children's Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increase their levels of physical activity Participants will be asked to utilize a smartphone program, called NUDGE that we have developed. NUDGE is a chatbot with evidence-based features known to help teens make progress toward health goal: * Set and review goals * Self-monitor progress * Provide feedback on goal attainment * Revise future goals
Primary Outcome
Recruitment: Our recruitment goal is 30 AYAs with CF.
Conditions Studied
Interventions
- OTHER Education
- BEHAVIORAL NUDGE
Study Locations (1)
Florida
- Nemours Childrens Health - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-18 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06616857 shows while recruiting
NCT06616857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 139-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Cystic Fibrosis (CF) appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.
NCT06616857 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06616857 about?
NCT06616857 is a clinical study titled "Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis". The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increa...
What is the current status of trial NCT06616857?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-02-18. Estimated completion is 2026-07.
What conditions does trial NCT06616857 study?
This clinical trial studies the following conditions: Cystic Fibrosis (CF).
What interventions are being tested in trial NCT06616857?
The interventions under investigation include: Education (OTHER), NUDGE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06616857?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06616857 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis (CF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06616857's enrollment target sits among peer trials
30 13th of 14 higher than 2 of 14 other Cystic Fibrosis (CF) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis (CF) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT With CF Self-Help Toolkit
RECRUITING · NA
-
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
RECRUITING · NA
-
CF Wellness Program
RECRUITING · NA
-
OnTrackCF: Engagement, Feasibility, and Acceptability Study
RECRUITING · NA
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
RECRUITING
-
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI